Fosaprepitant injection
Products billed under this code include Emend, Fosaprepitant.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Emend, Fosaprepitant.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Emend | Merck Sharp & Dohme LLC | 00006-3061-00 | 150 | $17.10 |
| Fosaprepitant | Hikma Pharmaceuticals USA Inc. | 00143-9384-01 | 150 | $17.10 |
| Fosaprepitant | Hikma Pharmaceuticals USA Inc. | 00143-9428-01 | 150 | $17.10 |
| Fosaprepitant | Northstar RxLLC | 16714-0248-01 | 150 | $17.10 |
| Fosaprepitant | Dr. Reddy's Laboratories Inc. | 43598-0859-11 | 150 | $17.10 |
| Fosaprepitant | Dr. Reddy's Laboratories Inc. | 43598-0948-11 | 150 | $17.10 |
| Fosaprepitant | Eugia US LLC | 55150-0299-01 | 150 | $17.10 |
| Fosaprepitant | Apotex Corp | 60505-6105-01 | 150 | $17.10 |
| Fosaprepitant | FreseniUS Kabi USA, LLC | 63323-0972-10 | 150 | $17.10 |
| Fosaprepitant | Mylan Institutional LLC | 67457-0889-10 | 150 | $17.10 |
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Fosaprepitant | BluePoint Laboratories | 68001-0523-36 | 150 | $17.10 |
| Fosaprepitant | Bluepoint Laboratories | 68001-0675-25 | 150 | $17.10 |
| Fosaprepitant | Athenex Pharmaceutical Division, LLC | 70860-0780-10 | 150 | $17.10 |
| Fosaprepitant | Athenex Pharmaceutical Division, LLC | 70860-0782-10 | 150 | $17.10 |
| Fosaprepitant | Athenex Pharmaceutical Division, LLC | 70860-0783-10 | 150 | $17.10 |
| Fosaprepitant | BE Pharmaceuticals Inc. | 71839-0104-01 | 150 | $17.10 |
| Fosaprepitant | Novadoz Pharmaceuticals LLC | 72205-0026-01 | 150 | $17.10 |
| Fosaprepitant | Novadoz Pharmaceuticals LLC | 72205-0054-01 | 150 | $17.10 |
| Fosaprepitant | Novadoz Pharmaceuticals LLC | 72205-0083-01 | 150 | $17.10 |
| Fosaprepitant | Northstar RxLLC | 72603-0450-01 | 150 | $17.10 |
| Fosaprepitant | Hepalink USA, Inc. | 81952-0911-01 | 150 | $17.10 |
| Fosaprepitant | Avenacy Inc. | 83634-0776-10 | 150 | $17.10 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $0.114 | −$0.009 | 1 MG | Fosaprepitant injection | v1, posted September 17, 2026 |
| 3Q26 | $0.123 | +$0.017 | 1 MG | Fosaprepitant injection | v1, posted September 15, 2026 |
| 2Q26 | $0.106 | +$0.001 | 1 MG | Fosaprepitant injection | v1, posted September 15, 2026 |
| 1Q26 | $0.105 | +$0.004 | 1 MG | Fosaprepitant injection | v1, posted September 15, 2026 |
| 4Q25 | $0.101 | −$0.013 | 1 MG | Fosaprepitant injection | v1, posted September 8, 2026 |
| 3Q25 | $0.114 | −$0.004 | 1 MG | Fosaprepitant injection | v1, posted March 10, 2026 |
| 2Q25 | $0.118 | −$0.002 | 1 MG | Fosaprepitant injection | v1, posted March 10, 2026 |
| 1Q25 | $0.12 | −$0.016 | 1 MG | Fosaprepitant injection | v1, posted December 19, 2025 |
| 4Q24 | $0.136 | −$0.03 | 1 MG | Fosaprepitant injection | v1, posted June 11, 2025 |
| 3Q24 | $0.166 | +$0.035 | 1 MG | Fosaprepitant injection | v1, posted June 11, 2025 |
| 2Q24 | $0.131 | −$0.007 | 1 MG | Fosaprepitant injection | v1, posted March 11, 2025 |
| 1Q24 | $0.138 | +$0.018 | 1 MG | Fosaprepitant injection | v1, posted December 19, 2024 |
| 4Q23 | $0.12 | −$0.022 | 1 MG | Fosaprepitant injection | v1, posted October 10, 2024 |
| 3Q23 | $0.142 | −$0.047 | 1 MG | Fosaprepitant injection | v1, posted June 5, 2024 |
| 2Q23 | $0.189 | +$0.014 | 1 MG | Fosaprepitant injection | v1, posted February 23, 2024 |
| 1Q23 | $0.175 | +$0.035 | 1 MG | Fosaprepitant injection | v1, posted December 6, 2023 |
| 4Q22 | $0.14 | −$0.043 | 1 MG | Fosaprepitant injection | v1, posted June 22, 2023 |
| 3Q22 | $0.183 | +$0.006 | 1 MG | Fosaprepitant injection | v1, posted June 9, 2023 |
| 2Q22 | $0.177 | −$0.013 | 1 MG | Fosaprepitant injection | v1, posted December 14, 2022 |
| 1Q22 | $0.19 | −$0.053 | 1 MG | Fosaprepitant injection | v1, posted June 8, 2022 |
| 4Q21 | $0.243 | −$0.089 | 1 MG | Fosaprepitant injection | v1, posted June 2, 2022 |
| 3Q21 | $0.332 | −$0.01 | 1 MG | Fosaprepitant injection | v1, posted June 2, 2022 |
| 2Q21 | $0.342 | −$0.075 | 1 MG | Fosaprepitant injection | v1, posted March 1, 2022 |
| 1Q21 | $0.417 | – | 1 MG | Fosaprepitant injection | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.